Targacept reported a net loss of $26.4 million in the fourth quarter of 2009, up from a loss of $5.4 million a year earlier, according to an earnings announcement.
Much of the loss was the result of a $16 million payment the Winston-Salem drug discovery firm made during the quarter as a license fee to the University of South Florida Research Foundation.
